Article Versions Notes

Li Z, Belitzky E, Blaha O, Cavaliere A, Katz SR, Aboian M, Melegari L, Rajabimoghadam K, Kurpiewski S, Zhu X, et al. ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers. 2023; 15(5):1589. https://doi.org/10.3390/cancers15051589

Li, Ziqi, Erika Belitzky, Ondrej Blaha, Alessandra Cavaliere, Samantha R. Katz, Mariam Aboian, Lindy Melegari, Khashayar Rajabimoghadam, Stephen Kurpiewski, Xiaohua Zhu, and et al. 2023. "ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer" Cancers 15, no. 5: 1589. https://doi.org/10.3390/cancers15051589

Li, Z., Belitzky, E., Blaha, O., Cavaliere, A., Katz, S. R., Aboian, M., Melegari, L., Rajabimoghadam, K., Kurpiewski, S., Zhu, X., & Marquez-Nostra, B. (2023). ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers, 15(5), 1589. https://doi.org/10.3390/cancers15051589